PATENT CLAIM ANALYSIS

Application Number: 16031254
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
Biomarker associated with Alzheimer's Disease (AD) and/or Mild Cognitive Impairment (MCI), where the biomarker is an intracellular or circulating microRNA and/or target protein thereof, and use thereof in methods for determining, diagnosing, monitoring AD, mild AD, moderate Ad, severe AD, MCI, early MCI, late MCI, and the like, as well as in methods for selecting candidate therapeutic compounds for treating same.

Claim (Index 4):
The method of  claim 3 , wherein processing the blood or plasma sample comprises centrifugation, sedimentation or cell sorting.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.54902
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14371628', '15390110', '14112765', '15553186', '14903164']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7630033768668093
- 35 USC 102 Novelty (BERT): 0.526026042888913
- Combined Prediction Score: 0.7393056434690197
- Mean Citation Score: 269.23051
- Max Citation Score: 294.98895
- Similarity Product: 181.3095810711085

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test